Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation

Summary

This is a Phase 1 randomized study to evaluate the safety, tolerability and efficacy of IV Ampion in improving the clinical course and outcomes of patients hospitalized with COVID-19 infection who require supplemental oxygen.

Timeline

Start

2020-07-27

Primary completion

2020-09-08

Completion

2020-11-30

Drugs

Indications